A classification of hemolytic uremic syndrome and thrombotic thrombocytopenic purpura and related disorders

被引:199
作者
Besbas, N.
Karpman, D.
Landau, D.
Loirat, C.
Proesmans, W.
Remuzzi, G.
Rizzoni, G.
Taylor, C. M. [1 ]
Van de Kar, N.
Zimmerhackl, L. B.
机构
[1] Childrens Hosp, Dept Nephrol, Birmingham B4 6NH, W Midlands, England
[2] Hacettepe Univ, Ankara, Turkey
[3] Lund Univ, S-22100 Lund, Sweden
[4] Soroka Med Ctr, IL-84101 Beer Sheva, Israel
[5] Hop Robert Debre, F-75019 Paris, France
[6] Katholieke Univ Leuven Hosp, B-3000 Louvain, Belgium
[7] Mario Negri Inst Pharmacol Res, I-24100 Bergamo, Italy
[8] Bambino Gesu Pediat Hosp, Rome, Italy
[9] Radboud Univ Nijmegen Med Ctr, Nijmegen, Netherlands
[10] Univ Innsbruck, A-6020 Innsbruck, Austria
关键词
hemolytic uremic syndrome; thrombotic thrombocytopenic purpura; etiology;
D O I
10.1038/sj.ki.5001581
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
The diagnostic terms hemolytic uremic syndrome (HUS) and thrombotic thrombocytopenic purpura (TTP) are based on historical and overlapping clinical descriptions. Advances in understanding some of the causes of the syndrome now permit many patients to be classified according to etiology. The increased precision of a diagnosis based on causation is important for considering logical approaches to treatment and prognosis. It is also essential for research. We propose a classification that accommodates both a current understanding of causation (level 1) and clinical association in cases for whom cause of disease is unclear (level 2). We tested the classification in a pediatric disease registry of HUS. The revised classification is a stimulus to comprehensive investigation of all cases of HUS and TTP and is expected to increase the proportion of cases in whom a level 1 etiological diagnosis is confirmed.
引用
收藏
页码:423 / 431
页数:9
相关论文
共 142 条
  • [101] A BOY WITH ACUTE-RENAL-FAILURE
    PROESMANS, W
    BATEN, E
    VANDAMME, B
    [J]. PEDIATRIC NEPHROLOGY, 1995, 9 (03) : 389 - 391
  • [102] Prospective surveillance of Canadian children with the haemolytic uraemic syndrome
    Proulx, F
    Sockett, P
    [J]. PEDIATRIC NEPHROLOGY, 2005, 20 (06) : 786 - 790
  • [103] Ray PE, 1998, SEMIN NEPHROL, V18, P396
  • [104] Remuzzi G, 2002, BLOOD, V100, P3842
  • [105] Thrombotic microangiopathy after renal transplantation in the United States
    Reynolds, JC
    Agodoa, LY
    Yuan, CM
    Abbott, KC
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 42 (05) : 1058 - 1068
  • [106] Mutations in human complement regulator, membrane cofactor protein (CD46), predispose to development of familial hemolytic uremic syndrome
    Richards, A
    Kemp, EJ
    Liszewski, MK
    Goodship, JA
    Lampe, AK
    Decorte, R
    Müslümanoglu, MH
    Kavukcu, S
    Filler, G
    Pirson, Y
    Wen, LS
    Atkinson, JP
    Goodship, THJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (22) : 12966 - 12971
  • [107] THE HISTOPATHOLOGY OF THE HEMOLYTIC UREMIC SYNDROME ASSOCIATED WITH VEROCYTOTOXIN-PRODUCING ESCHERICHIA-COLI INFECTIONS
    RICHARDSON, SE
    KARMALI, MA
    BECKER, LE
    SMITH, CR
    [J]. HUMAN PATHOLOGY, 1988, 19 (09) : 1102 - 1108
  • [108] COMPARISON OF PLASMA-EXCHANGE WITH PLASMA INFUSION IN THE TREATMENT OF THROMBOTIC THROMBOCYTOPENIC PURPURA
    ROCK, GA
    SHUMAK, KH
    BUSKARD, NA
    BLANCHETTE, VS
    KELTON, JG
    NAIR, RC
    SPASOFF, RA
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (06) : 393 - 397
  • [109] Rougier N, 1998, J AM SOC NEPHROL, V9, P2318
  • [110] EPIDEMIOLOGY OF HEMOLYTIC-UREMIC SYNDROME IN CANADIAN CHILDREN FROM 1986 TO 1988
    ROWE, PC
    ORRBINE, E
    WELLS, GA
    MCLAINE, PN
    [J]. JOURNAL OF PEDIATRICS, 1991, 119 (02) : 218 - 224